Sidewinder Therapeutics is a San Diego based precision antibody-drug conjugate (ADC) company founded in 2023 with a Series A investment from OrbiMed. The company is focused on developing first-in-class bispecific ADC therapeutics to treat solid tumor indications.
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
